Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Latest Guidelines “Dropped” After Scandal Over EXCEL Results

The European Association for Cardio-Thoracic Surgery (EACTS) formally withdrew its support for the latest coronary revascularization guidelines following a BBC investigation suggesting that data from the EXCEL trial might have been manipulated.

Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

The recommendations for left main coronary artery revascularization featured in the 2018 guidelines, which were written jointly with the European Society of Cardiology (ESC), were mainly based on the EXCEL trial.

That is why EACTS withdrew its support for its own guidelines after becoming aware, through a BBC investigation, of the fact that patients who underwent angioplasty experienced significantly more infarctions that those who underwent surgery. Between the publication of the 2018 guidelines and today, many patients may have received the wrong clinical advice from their cardiologists.


Read also: The EXCEL Authors’ Answer to the BBC Investigation.


David Taggart, MD, PhD (University of Oxford, England), lead investigator of the EXCEL surgical committee during the recruitment phase, was very critical of its results; he even requested that his name be removed from the New England Journal of Medicine paper in the 5-year follow-up. Who would refuse to be the author of a paper published in the most prestigious medicine journal in the world? Clearly, someone who suspected that the results were not right.

After the EXCEL trial was published in NEJM in 2016, the guidelines were updated in 2018 and coronary angioplasty received a class IA recommendation for patients with a low SYNTAX score (the same recommendation for surgery). For patients with left main lesions and intermediate and high SYNTAX scores, the recommendations were class IIA and III, respectively. Surgery remains a class IA recommendation, regardless of SYNTAX score.

At 3 years, the EXCEL trial showed no difference in the risk of death, infarction, or stroke between patients with left main disease and low-to-intermediate SYNTAX score treated with angioplasty and those treated with surgery. However, the BBC investigation reported that, according to the Third Universal Definition for infarction, the rate for this event was 80% higher in the angioplasty group than in the surgical group.


Read also: Mechanisms of Infarction in Coronary Arteries with Non-Significant Lesions.


The EXCEL results were absolutely crucial for the 2018 guidelines update; this is why such a controversy arose with the BBC investigation.

The rate of acute myocardial infarction as identified by the Third Universal Definition was listed as one of the secondary endpoints in the study protocol. However, for some reason, it was not reported in the NEJM paper.

Choosing a definition for infarction is more complex than it might appear, and the interventional committee and the surgical committee both agreed on the definition used on EXCEL as the primary endpoint (an unprecedented team effort for an angioplasty vs. surgery study). According to this definition, the results are similar between both revascularization strategies. Using the Third Universal Definition changes the results and there is no problem with that: the definition changes and so do results. The problem was the omission of these data in the article.

We expect formal explanations from the authors so as to clarify the situation in the next few days.

Original title: Surgeons withdraw support for heart disease advice.

Reference: Cohen D et al. BBC News.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...